https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:16917 Tue 31 Jul 2018 16:15:02 AEST ]]> Moving towards a Treatable Traits model of care for the management of obstructive airways diseases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48632 Fri 24 Mar 2023 10:57:01 AEDT ]]>